We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+32.2%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$2.52B
AUM Growth
+$1.12B
(+80%)
Cap. Flow
+$772M
Cap. Flow
% of AUM
30.59%
Top 10 Holdings %
Top 10 Hldgs %
26.22%
Holding
205
New
69
Increased
52
Reduced
26
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$62.5M |
| 2 |
Johnson & Johnson
JNJ
|
+$61M |
| 3 |
Fidelity National Information Services
FIS
|
+$54.2M |
| 4 |
KLA
KLAC
|
+$44.1M |
| 5 |
PayPal
PYPL
|
+$41.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$65.7M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$46.8M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$46.5M |
| 4 |
IMMU
Immunomedics Inc
IMMU
|
+$41.2M |
| 5 |
Analog Devices
ADI
|
+$23.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 46.91% |
| 2 | Technology | 35.52% |
| 3 | Communication Services | 5.66% |
| 4 | Consumer Discretionary | 4.26% |
| 5 | Industrials | 2.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Fidelity National Information Services
FIS
$21.5B
| $95.2M | 3.77% |
709,723
+412,392
| +139% | +$54.2M |
|
|
2
Intel
INTC
$464B
| $79.9M | 3.16% |
1,335,260
+1,044,515
| +359% | +$62.5M |
|
|
HZNP
3
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $79M | 3.13% |
1,421,974
+148,480
| +12% | +$6.35M |
|
4
Applied Materials
AMAT
$426B
| $72.8M | 2.88% |
1,203,467
+213,234
| +22% | +$11.5M |
|
5
Global Payments
GPN
$22.1B
| $63.5M | 2.52% |
374,322
+225,934
| +152% | +$37.6M |
|
|
SGEN
6
DELISTED
Seagen Inc. Common Stock
SGEN
| $59.9M | 2.37% |
352,417
-11,916
| -3% | -$1.78M |
|
|
7
Johnson & Johnson
JNJ
$634B
| $58.9M | 2.33% |
+418,880
| New | +$61M |
|
|
8
PayPal
PYPL
$49.5B
| $52M | 2.06% |
+298,327
| New | +$41.2M |
|
9
Amphenol
APH
$188B
| $50.6M | 2% |
2,111,492
+257,068
| +14% | +$5.74M |
|
|
10
KLA
KLAC
$275B
| $50.2M | 1.99% |
+2,581,680
| New | +$44.1M |
|
11
eBay
EBAY
$48.6B
| $48.4M | 1.92% |
+922,590
| New | +$39M |
|
|
ATVI
12
DELISTED
Activision Blizzard
ATVI
| $47.6M | 1.88% |
626,781
+309,166
| +97% | +$21.6M |
|
13
Vishay Intertechnology
VSH
$5.86B
| $46.8M | 1.85% |
3,064,192
+2,322,582
| +313% | +$36.1M |
|
14
McKesson
MCK
$98.5B
| $46M | 1.82% |
299,525
+200,230
| +202% | +$28.9M |
|
15
Arrow Electronics
ARW
$10.9B
| $44.7M | 1.77% |
651,321
+482,416
| +286% | +$30.5M |
|
16
Eli Lilly
LLY
$1.07T
| $43.2M | 1.71% |
263,029
+52,636
| +25% | +$8.08M |
|
17
NXP Semiconductors
NXPI
$68B
| $42.9M | 1.7% |
375,858
+362,185
| +2,649% | +$36.2M |
|
18
Qorvo
QRVO
$7.63B
| $42M | 1.66% |
+379,656
| New | +$37.6M |
|
|
WBA
19
DELISTED
Walgreens Boots Alliance
WBA
| $41.7M | 1.65% |
984,510
+860,062
| +691% | +$36.5M |
|
20
Zoetis
ZTS
$31.6B
| $36.3M | 1.44% |
265,016
+199,593
| +305% | +$26.1M |
|
21
Alkermes
ALKS
$8.82B
| $35.9M | 1.42% |
+1,848,542
| New | +$30M |
|
|
ZNGA
22
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $34.2M | 1.35% |
3,584,517
+900,464
| +34% | +$7.38M |
|
23
Zymeworks
ZYME
$1.68B
| $34.1M | 1.35% |
944,525
+500,191
| +113% | +$18.4M |
|
24
Centene
CNC
$31.3B
| $33.9M | 1.34% |
+533,575
| New | +$34.7M |
|
|
KDMN
25
DELISTED
Kadmon Holdings, Inc.
KDMN
| $30.9M | 1.22% |
6,030,531
+2,559,181
| +74% | +$11.5M |
|
Similar funds
KAS
PAM
TCIIS
Woodline Partners's Q2 2020 Portfolio in Review
As of Q2 2020, Woodline Partners held 205 positions worth $2.52B, up 80% from $1.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Woodline Partners deployed $772M of net new capital in Q2 2020, opening 69 new positions and adding to 52 existing holdings. Its largest new stake was Johnson & Johnson: 418,880 shares worth $58.9M.
By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 46% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Immunomedics Inc, an estimated $41.2M trimmed.
- Woodline Partners's largest Q2 2020 buy was Johnson & Johnson: 418,880 shares worth $58.9M.
- Woodline Partners added most to Intel in Q2 2020, an estimated $62.5M increase.
- Woodline Partners's biggest Q2 2020 reduction was Immunomedics Inc, cutting an estimated $41.2M.
- Woodline Partners fully exited Pfizer in Q2 2020, selling an estimated $65.7M.
- Woodline Partners's ten largest holdings make up 26% of its $2.52B portfolio in Q2 2020.
- Woodline Partners opened 69 new positions and closed 58 in Q2 2020.
- Woodline Partners's portfolio value rose 80% quarter-over-quarter to $2.52B.
Based on Woodline Partners's 13F filing for Q2 2020, filed 14 Aug 2020.